Please login to the form below

Not currently logged in
Email:
Password:

European Cancer Congress 2013

This page shows the latest European Cancer Congress 2013 news and features for those working in and with pharma, biotech and healthcare.

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

Data from the LUME-Lung 1 study was presented at the European Cancer Congress in Amsterdam and showed that in patients who have advanced non-small cell lung cancer (NSCLC) with ... The cancer is the most common of NSCLC – accounting for around 40 per

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics